New wearable device listens for COPD Flare-Ups from home
NCT ID NCT06544928
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a wearable device called the RESP™ Biosensor that listens to lung sounds and chest movements. It is designed to help monitor people with COPD after they leave the hospital. The goal is to see if the device can detect early signs of a COPD flare-up, so patients can get help sooner. The study will follow 20 adults aged 40 to 80 who have recently been hospitalized for a COPD exacerbation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RESP™ Biosensor (wearable device)
What this could lead to
If successful, this could lead to a reliable way to monitor COPD patients at home and catch worsening symptoms early, potentially reducing hospital visits.
What could go wrong
This is a very small, early feasibility study with only 20 participants. It is observational, so it won't prove the device improves health outcomes. The device may not detect exacerbations accurately in real-world conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jefferson Einstein Philadelphia Hospital
Philadelphia, Pennsylvania, 19141, United States